The widespread use of advanced molecular techniques has led to the identification of several tumor types with PLAG1 gene fusions some of which also affect the skin and soft tissues. Herein, we present a 38-year-old female with a subcutaneous tumor affecting her forearm, which does not seem to fit into any currently recognized entity. It was a well-circumscribed tumor measuring 6 × 4,5 × 4 cm. It had a thick capsule composed of bland spindle cells forming palisades and Verocay body-like structures within a myxocollagenous background. Scattered calcifications were dispersed throughout the lesion. No cytological atypia, mitotic activity, or necrosis were present. Targeted NGS revealed a SOX10::PLAG1 fusion and fluorescent in situ hybridization confirmed the presence of PLAG1 gene rearrangement. The neoplastic cells showed a diffuse immunohistochemical expression of S100, SOX10, and PLAG1, as well as patchy desmin and CD34 positivity. The methylation profile of this tumor did not match any other entity covered by the DKFZ sarcoma classifier and apart from the gain of chromosome 12, the copy number profile was normal. The tumor was completely excised, and the patient has been free of disease for 4 years since the excision. While more cases are needed to confirm this tumor as a distinct entity, we propose a provisional name "SOX10::PLAG1-rearranged calcifying spindle cell tumor."

Bioptica Laboratory Ltd Plzen Czech Republic

Department of Pathology Charles University Faculty of Medicine in Plzen Plzen Czech Republic

Department of Pathology Hacettepe University Faculty of Medicine Ankara Turkey

See more in PubMed

J. Asp, F. Persson, M. Kost‐Alimova, and G. Stenman, “CHCHD7‐PLAG1 and TCEA1‐PLAG1 Gene Fusions Resulting From Cryptic, Intrachromosomal 8q Rearrangements in Pleomorphic Salivary Gland Adenomas,” Genes, Chromosomes & Cancer 45 (2006): 820–828.

K. Fritchie, L. Wang, Z. Yin, et al., “Lipoblastomas Presenting in Older Children and Adults: Analysis of 22 Cases With Identification of Novel PLAG1 Fusion Partners,” Modern Pathology 34 (2021): 584–591.

C. R. Antonescu, L. Zhang, S. Y. Shao, et al., “Frequent PLAG1 Gene Rearrangements in Skin and Soft Tissue Myoepithelioma With Ductal Differentiation,” Genes, Chromosomes & Cancer 52 (2013): 675–682.

C. T. Chung, C. R. Antonescu, B. C. Dickson, et al., “Pediatric Fibromyxoid Soft Tissue Tumor With PLAG1 Fusion: A Novel Entity?” Genes, Chromosomes & Cancer 60 (2021): 263–271.

J. A. Arias‐Stella, 3rd, R. Benayed, E. Oliva, et al., “Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors,” The American Journal of Surgical Pathology 43 (2019): 382–388.

E. Russell‐Goldman, A. Dubuc, and J. Hanna, “Differential Expression of PLAG1 in Apocrine and Eccrine Cutaneous Mixed Tumors: Evidence for Distinct Molecular Pathogenesis,” The American Journal of Dermatopathology 42 (2020): 251–257.

M. K. Hibbard, H. P. Kozakewich, P. Dal Cin, et al., “PLAG1 Fusion Oncogenes in Lipoblastoma,” Cancer Research 60 (2000): 4869–4872.

C. Koelsche, D. Schrimpf, D. Stichel, et al., “Sarcoma Classification by DNA Methylation Profiling,” Nature Communications 12 (2021): 498.

A. Skalova, A. Agaimy, T. Vanecek, et al., “Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts,” The American Journal of Surgical Pathology 45 (2021): 1–13.

N. Klubickova, M. Michal, Z. Kinkor, et al., “Poorly Differentiated Extra‐Axial Extraskeletal Chordoma Diagnosed by Methylation Profiling: Case Report and Analysis of Brachyury Expression in SWI/SNF‐Deficient Tumors,” Virchows Archiv 484 (2023):621–627.

J. A. Plaza, T. Brenn, C. Chung, et al., “Histomorphological and Immunophenotypical Spectrum of Cutaneous Myoepitheliomas: A Series of 35 Cases,” Journal of Cutaneous Pathology 48 (2021): 847–855.

V. Y. Jo, “Myoepithelial Tumors: An Update,” Surgical Pathology Clinics 8 (2015): 445–466.

N. Macagno, T. Kervarrec, S. Thanguturi, et al., “SOX10‐Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine‐Type and Apocrine‐Type Cutaneous Mixed Tumors,” Modern Pathology 37, no. 3 (2024): 100430.

S. Santisukwongchote, P. S. Thorner, T. Desudchit, et al., “Pediatric Fibromyxoid Tumor With PLAG1 Fusion: An Emerging Entity With a Novel Intracranial Location,” Neuropathology: Official Journal of the Japanese Society of Neuropathology 42 (2022): 315–322.

K. Kas, M. L. Voz, E. Roijer, et al., “Promoter Swapping Between the Genes for a Novel Zinc Finger Protein and Beta‐Catenin in Pleiomorphic Adenomas With t(3;8)(p21;q12) Translocations,” Nature Genetics 15 (1997): 170–174.

C. Pusch, E. Hustert, D. Pfeifer, et al., “The SOX10/Sox10 Gene From Human and Mouse: Sequence, Expression, and Transactivation by the Encoded HMG Domain Transcription Factor,” Human Genetics 103 (1998): 115–123.

M. Wegner, “From Head to Toes: The Multiple Facets of sox Proteins,” Nucleic Acids Research 27 (1999): 1409–1420.

K. S. Hoek, O. M. Eichhoff, N. C. Schlegel, et al., “In Vivo Switching of Human Melanoma Cells Between Proliferative and Invasive States,” Cancer Research 68 (2008): 650–656.

K. S. Hoek, N. C. Schlegel, P. Brafford, et al., “Metastatic Potential of Melanomas Defined by Specific Gene Expression Profiles With No BRAF Signature,” Pigment Cell Research 19 (2006): 290–302.

C. Capparelli, T. J. Purwin, M. Glasheen, et al., “Targeting SOX10‐Deficient Cells to Reduce the Dormant‐Invasive Phenotype State in Melanoma,” Nature Communications 13 (2022): 1381.

J. R. Dutton, A. Antonellis, T. J. Carney, et al., “An Evolutionarily Conserved Intronic Region Controls the Spatiotemporal Expression of the Transcription Factor Sox10,” BMC Developmental Biology 8 (2008): 105.

M. Miettinen, P. A. McCue, M. Sarlomo‐Rikala, et al., “Sox10—A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue,” The American Journal of Surgical Pathology 39 (2015): 826–835.

R. P. Graham, S. Dry, X. Li, et al., “Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathologic, Proteomic, and Genomic Study,” The American Journal of Surgical Pathology 35 (2011): 1615–1625.

C. S. Carter and R. M. Patel, “Ossifying Fibromyxoid Tumor: A Review With Emphasis on Recent Molecular Advances and Differential Diagnosis,” Archives of Pathology & Laboratory Medicine 143 (2019): 1504–1512.

F. Puls, J. Hofvander, L. Magnusson, et al., “FN1‐EGF Gene Fusions Are Recurrent in Calcifying Aponeurotic Fibroma,” The Journal of Pathology 238 (2016): 502–507.

L. A. Doyle, E. Moller, P. Dal Cin, et al., “MUC4 Is a Highly Sensitive and Specific Marker for Low‐Grade Fibromyxoid Sarcoma,” The American Journal of Surgical Pathology 35 (2011): 733–741.

E. Baranov, M. J. McBride, A. M. Bellizzi, et al., “A Novel SS18‐SSX Fusion‐Specific Antibody for the Diagnosis of Synovial Sarcoma,” The American Journal of Surgical Pathology 44 (2020): 922–933.